Apatinib+Camrelizumab+SOX + Preoperative Radiotherapy for adenocarcinoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Jun 2025: Trial registered, NCT07026149

The trials

NCT07026149: Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

State
Under way
Phase
Phase 2
People
30 planned
Started
8 Jun 2025
Primary completion
1 Sep 2025
Arms
Arm 1
Results
None posted
  1. 18 Jun 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.